AAP
DXCM icon

Aristotle Atlantic Partners’s DexCom DXCM Stock Holding History

Aristotle Atlantic Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.8M Buy
251,485
+15,874
+7% +$1.11M 0.74% 43
2025
Q4 		$15.6M Buy
235,611
+42,334
+22% +$2.74M 0.72% 43
2025
Q3 		$13M Buy
+193,277
New +$15.3M 0.38% 51
2024
Q4 		– Sell
-199,445
Closed -$13.4M – 92
2024
Q3 		$13.4M Buy
199,445
+191
+0.1% +$15.7K 0.42% 53
2024
Q2 		$22.6M Sell
199,254
-1,208
-0.6% -$153K 0.73% 37
2024
Q1 		$27.8M Sell
200,462
-2,692
-1% -$338K 0.91% 33
2023
Q4 		$25.2M Buy
203,154
+2,323
+1% +$237K 0.89% 38
2023
Q3 		$18.7M Sell
200,831
-1,443
-0.7% -$163K 0.75% 45
2023
Q2 		$26M Buy
202,274
+36,544
+22% +$4.42M 0.98% 35
2023
Q1 		$19.3M Buy
165,730
+50
+0% +$5.6K 0.99% 38
2022
Q4 		$18.8M Sell
165,680
-17
-0% -$1.87K 1.05% 33
2022
Q3 		$13.3M Buy
165,697
+1,277
+0.8% +$108K 0.81% 44
2022
Q2 		$12.3M Buy
164,420
+2,916
+2% +$266K 0.94% 30
2022
Q1 		$20.7M Buy
161,504
+640
+0.4% +$70K 1.28% 27
2021
Q4 		$21.6M Buy
160,864
+776
+0.5% +$112K 1.25% 26
2021
Q3 		$21.9M Buy
160,088
+1,276
+0.8% +$161K 1.45% 28
2021
Q2 		$17M Buy
158,812
+156
+0.1% +$15K 1.12% 30
2021
Q1 		$14.3M Buy
158,656
+152
+0.1% +$14.3K 1.04% 33
2020
Q4 		$14.7M Buy
158,504
+3,696
+2% +$330K 1.13% 33
2020
Q3 		$16M Buy
154,808
+144
+0.1% +$15K 1.41% 27
2020
Q2 		$15.7M Buy
154,664
+40,496
+35% +$3.62M 1.51% 26
2020
Q1 		$7.69M Buy
+114,168
New +$7.1M 1.17% 30

Other funds holding DXCM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Aristotle Atlantic Partners's DXCM Position: Q1 2026 in Review

Aristotle Atlantic Partners increased its DexCom (DXCM) stake by 6.7% in Q1 2026, buying an estimated $1.11M and bringing the position to 251,485 shares worth $15.8M. The position accounts for 0.74% of the portfolio, ranked #43.

Aristotle Atlantic Partners first reported a position in DXCM in Q1 2020 and has held it in 22 quarters since. The position peaked at $27.8M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Aristotle Atlantic Partners held 251,485 shares of DexCom worth $15.8M as of Q1 2026.
  • Aristotle Atlantic Partners bought 15,874 DexCom shares in Q1 2026, an estimated $1.11M.
  • DexCom made up 0.74% of Aristotle Atlantic Partners's portfolio in Q1 2026, its #43 holding.
  • Aristotle Atlantic Partners first reported a position in DexCom in Q1 2020 and has held it in 22 quarters since.
  • Aristotle Atlantic Partners's DexCom position peaked at $27.8M in Q1 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Aristotle Atlantic Partners's 13F filing for Q1 2026, filed 15 May 2026.